Multi-Cancer Early Detection (MCED) Test

About Owlstone Medical

Owlstone Medical is the recognized leader in breath-based VOC biomarker research and diagnostic test development. Its core Breath Biopsy® platform enables the reliable collection and analysis of breath samples, offering a completely non-invasive window into systemic health for early disease detection and treatment monitoring. The company operates a dual business model, providing research products and services to partners while advancing its own pipeline of diagnostic tests, supported by significant non-dilutive funding and venture investment. Its vision is to become the global standard in breath analysis, with active programs targeting multi-cancer early detection and specific conditions like cystic fibrosis.

Therapeutic Areas